Clinical Trial Update: Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating lactoferrin as an adjunct therapy for hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Al-Azhar University | Conditions: Hepatic Encephalopathy | Phase 2 | Status: UNKNOWN